11551270

Source:http://linkedlifedata.com/resource/pubmed/id/11551270

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C1874285, umls-concept:C2362914
pubmed:issue	5
pubmed:dateCreated	2001-9-11
pubmed:abstractText	The aim of this paper is to alert the medical community to the potential risk of clinical depression following the use of antiglaucoma medication.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0111052
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Betaxolol, http://linkedlifedata.com/resource/pubmed/chemical/Ophthalmic Solutions, http://linkedlifedata.com/resource/pubmed/chemical/Sympatholytics
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0004-8674
pubmed:author	pubmed-author:MaguireKK, pubmed-author:SchweitzerII, pubmed-author:TuckwellVV
pubmed:issnType	Print
pubmed:volume	35
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	569-71
pubmed:dateRevised	2009-11-11
pubmed:meshHeading	pubmed-meshheading:11551270-Adrenergic beta-Antagonists, pubmed-meshheading:11551270-Aged, pubmed-meshheading:11551270-Betaxolol, pubmed-meshheading:11551270-Depressive Disorder, Major, pubmed-meshheading:11551270-Glaucoma, pubmed-meshheading:11551270-Humans, pubmed-meshheading:11551270-Male, pubmed-meshheading:11551270-Ophthalmic Solutions, pubmed-meshheading:11551270-Recurrence, pubmed-meshheading:11551270-Sympatholytics
pubmed:year	2001
pubmed:articleTitle	Antiglaucoma medication and clinical depression.
pubmed:affiliation	Department of Psychiatry, The Melbourne Clinic, University of Melbourne, 130 Church Street, Richmond, Victoria 3121, Australia. i.schweitzer@medicine.unimelb.edu.au
pubmed:publicationType	Journal Article, Case Reports